Filter
189
Filtered Results: 189
Text search:
Bedaquiline
Featured
Recommendations
34
New Publications
77
Language
Document type
No document type
121
Guidelines
25
Studies & Reports
19
Manuals
10
Fact sheets
5
Training Material
3
Situation Updates
3
Strategic & Response Plan
3
Countries / Regions
Western and Central Europe
20
Eastern Europe
16
India
12
Germany
4
Asia
3
South Africa
3
Uganda
3
Ethiopia
3
El Salvador
2
Latin America and the Carribbean
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Bolivia
2
Argentina
2
Russia
2
Nepal
1
Kenya
1
Ukraine
1
Nigeria
1
Estonia
1
Philippines
1
Global
1
Dominican Republic
1
Paraguay
1
Bangladesh
1
Brazil
1
Namibia
1
Romania
1
Georgia
1
Botswana
1
Zambia
1
Authors & Publishers
Publication Years
Category
TB
35
Policies & Guidelines HIV & TB
32
Drugs & Medical Equipment
6
Statistics
5
Pediatrics
3
Bacteriology
2
Studies & Reports
2
Disease Prevention & Control
2
Communicable Diseases
1
Buruli Ulcer
1
COVID-19
1
x MEDBOX Issue Brief & Annual Reports x
1
Palliative Care
1
Countries
1
Policies
1
Guidelines
1
Capacity Building
1
Palliative Care
1
General Guidelines
1
Toolboxes
Drug resistant TB
37
Adults
18
Detection & Diagnosis
18
Prevention & Control
16
Children
13
Reports
10
Eastern Europe & Central Asia
10
Research & Access
7
Policies & Strategies
6
Childhood TB
6
Training
6
General
5
Other Countries
4
Disease Prevention & Control
4
Germany
4
SEAR (South-east Asia Region)
4
Moldova
3
TB & Other Vulnerable Populations
3
Drug resistance
3
Essential Medicines
3
Essential Medicines & Devices Lists
3
HIV &TB
3
Co-Morbidities (except TB)
3
TB & Prisoners
3
Ukraine
2
Georgia
2
Russia
2
Ethiopia
2
Studies
2
TB/COVID-19
2
Advocacy & Communication
2
Latin America
2
El Salvador
2
Prices and Patents
2
Argentina
2
Romania
2
Western & Central Europe
2
TB
2
Biosafety
1
Azerbaijan
1
Clinical Aspects, Treatment & Prevention
1
Clinical Aspects
1
Children & Adolescents
1
TB
1
Prophylaxis
1
African Region
1
Country Guidelines
1
Belarus
1
Communication & Training
1
General
1
Research & Development
1
General
1
Country specific documents
1
Global Impact: Socio-economic, health services, TB & HIV
1
Latin America
1
Estonia
1
Rational use of Medicine
1
Health Care In Conflict Settings
1
Studies & Reports
1
Armenia
1
Policies and guidelines
1
Regional Reports & Guidelines, others
1
Human Rights & the Right to Health
1
TB/HIV Global
1
Latin America & the Carribean
1
Assessment
1
TB/HIV Coinfection
1
Kazakhstan
1
AmR (Region of Americas)
1
Antiretroviral Treatment ART
1
Kenya
1
AMR
1
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
2nd edition
INT J TUBERC LUNG DIS 22(2):197–205 http://dx.doi.org/10.5588/ijtld.17.0245
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
Topics in Antiviral Medicine 25 Issue 2 May/June 2017
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt...
Lessons from the STEP-TB Project.
Accessed November 2017.
A survival guide for clinicans.
3rd edition.
Policy framework.
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac...
